These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 956555)

  • 1. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity.
    Tomar RH; Knight R; Stern M
    J Allergy Clin Immunol; 1976 Jul; 58(1 PT. 2):190-7. PubMed ID: 956555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine.
    Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor.
    O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF
    Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxanthine is the principal inhibitor of murine oocyte maturation in a low molecular weight fraction of porcine follicular fluid.
    Downs SM; Coleman DL; Ward-Bailey PF; Eppig JJ
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):454-8. PubMed ID: 2982158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity.
    Lawton JW; Darg C; Pepper D; Kay AB
    J Immunol Methods; 1977; 16(2):119-29. PubMed ID: 881554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor (TFd). Part I. Some physicochemical data.
    Komorowska-Rycerz A; Szczypiorska D; Izdebska-Szymona K; Kociński W; Zarzycka A; Rzucidło L
    Mater Med Pol; 1979; 11(4):317-9. PubMed ID: 553982
    [No Abstract]   [Full Text] [Related]  

  • 7. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
    J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human transfer factor: fractionation and biologic activity.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of a small molecular weight inhibitor of cyclic nucleotide phosphodiesterase from bovine brain.
    Liang CM; Liu YP; Chabner BA
    Biochim Biophys Acta; 1979 Nov; 571(1):63-9. PubMed ID: 227469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hypoxanthine in bovine follicular fluid.
    Kadam AL; Koide SS
    J Pharm Sci; 1990 Dec; 79(12):1077-82. PubMed ID: 2079654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the chemical composition and biological properties of transfer factor.
    Krohn K; Uotila A; Väisänen J; Gröhn P
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.
    Schroder I; Rovensky J
    Allergol Immunopathol (Madr); 1982; 10(3):171-6. PubMed ID: 7148610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The preparation and characterization of transfer factor (author's transl)].
    Schröder I; Werner H; Lorenz U; Köhler H; Jenssen HL
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):365-71. PubMed ID: 126568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor--a lymphocyte cell surface component.
    Schröder I; Lüneburg S
    Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin test conversion following transfer factor. A double-blinded study of normal individuals.
    Neidhart JA; Christakis N; Metz EN; Balcerzak SP; LoBuglio AF
    J Allergy Clin Immunol; 1978 Feb; 61(2):115-8. PubMed ID: 340492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical characterization of the purified component of specific transfer factor in the leukocyte dialysates from HSV-1 immunized goats.
    Qi HY; Wan ZF; Su CZ
    Acta Virol; 1992 May; 36(3):239-44. PubMed ID: 1360751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification and significance of hypoxanthine in dialyzable transfer factor.
    Kirkpatrick CH; Robinson LB; Smith TK
    Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of transfer factor on cystic acne.
    Gröhn P; Kuokkanen K; Krohn K
    Acta Derm Venereol; 1978; 58(2):153-5. PubMed ID: 76396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UV-absorbance profile of human leukocytic ultrafiltrate after affinity chromatography on immobilized m-aminophenyl boronic acid: implication for transfer factor purification.
    Borvák J; Mayer V
    Acta Virol; 1985 Mar; 29(2):119-28. PubMed ID: 2860795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.